4/A

PRIMARY DOCUMENT

Company: Phio Pharmaceuticals Corp.
Filed: March 21, 2014
Period of Report: February 25, 2014
Accession Number: 0001572407-14-000003

View Document ↗ View on SEC.gov ↗